A detailed history of Nikulski Financial, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nikulski Financial, Inc. holds 2,754 shares of AMGN stock, worth $912,372. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,754
Previous 2,710 1.62%
Holding current value
$912,372
Previous $780,000 0.38%
% of portfolio
0.26%
Previous 0.29%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $11,830 - $14,280
44 Added 1.62%
2,754 $783,000
Q4 2023

Feb 01, 2024

BUY
$255.7 - $288.46 $182,314 - $205,671
713 Added 35.7%
2,710 $780,000
Q3 2023

Oct 17, 2023

BUY
$218.65 - $271.46 $108,231 - $134,372
495 Added 32.96%
1,997 $536,000
Q2 2023

Jul 27, 2023

BUY
$214.27 - $253.37 $85,708 - $101,348
400 Added 36.3%
1,502 $333,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $33,868 - $41,280
150 Added 15.76%
1,102 $266,000
Q4 2022

Jan 25, 2023

BUY
$229.03 - $291.01 $218,036 - $277,041
952 New
952 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $177B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nikulski Financial, Inc. Portfolio

Follow Nikulski Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikulski Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikulski Financial, Inc. with notifications on news.